Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Meningococcal Conjugate Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Meningococcal Conjugate Vaccinemarket, defines the market attractiveness level of Meningococcal Conjugate Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Meningococcal Conjugate Vaccine industry, describes the types of Meningococcal Conjugate Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Meningococcal Conjugate Vaccine market and the development prospects and opportunities of Meningococcal Conjugate Vaccine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Meningococcal Conjugate Vaccine market in Chapter 13.
By Player:
Sanofi
GlaxoSmithKline
Pfizer
By Type:
Menactra
MENVEO
By End-User:
Children
Adults
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Meningococcal Conjugate Vaccine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Meningococcal Conjugate Vaccine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Meningococcal Conjugate Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Meningococcal Conjugate Vaccine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Meningococcal Conjugate Vaccine Market Analysis and Outlook to 2022
-
7.1 Global Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
7.2 United States Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
7.3 Europe Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
7.4 China Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
7.5 Japan Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
7.6 India Meningococcal Conjugate Vaccine Consumption (2017-2022)
-
7.7 South Korea Meningococcal Conjugate Vaccine Consumption (2017-2022)
8 Region and Country-wise Meningococcal Conjugate Vaccine Market Analysis and Outlook to 2028
-
8.1 Global Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
8.2 United States Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
8.3 Europe Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
8.4 China Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
8.5 Japan Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
8.6 India Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
-
8.7 South Korea Meningococcal Conjugate Vaccine Consumption Forecast (2022-2028)
9 Global Meningococcal Conjugate Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Meningococcal Conjugate Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Menactra Consumption and Growth Rate (2017-2022)
-
9.1.2 Global MENVEO Consumption and Growth Rate (2017-2022)
-
9.2 Global Meningococcal Conjugate Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Children Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adults Consumption and Growth Rate (2017-2022)
10 Global Meningococcal Conjugate Vaccine Market Outlook by Types and Applications to 2028
-
10.1 Global Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Menactra Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global MENVEO Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Children Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Adults Consumption Forecast and Growth Rate (2022-2028)
11 Global Meningococcal Conjugate Vaccine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Meningococcal Conjugate Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Meningococcal Conjugate Vaccine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Meningococcal Conjugate Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Meningococcal Conjugate Vaccine Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Meningococcal Conjugate Vaccine Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Meningococcal Conjugate Vaccine Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Meningococcal Conjugate Vaccine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Meningococcal Conjugate Vaccine
-
Figure Meningococcal Conjugate Vaccine Picture
-
Table Global Meningococcal Conjugate Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Meningococcal Conjugate Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Meningococcal Conjugate Vaccine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Meningococcal Conjugate Vaccine Consumption by Country (2017-2022)
-
Figure United States Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure China Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Meningococcal Conjugate Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Meningococcal Conjugate Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Meningococcal Conjugate Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Menactra Consumption and Growth Rate (2017-2022)
-
Figure Global MENVEO Consumption and Growth Rate (2017-2022)
-
Figure Global Children Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Menactra Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MENVEO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Children Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Meningococcal Conjugate Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Meningococcal Conjugate Vaccine Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Meningococcal Conjugate Vaccine Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Meningococcal Conjugate Vaccine Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Meningococcal Conjugate Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Meningococcal Conjugate Vaccine Product and Service
-
